Malarone vs Tafenoquine (Arakoda): Which Malaria Pill Fits Your Trip?

Malarone (atovaquone-proguanil) and Arakoda (tafenoquine) are both first-line options the CDC considers equally effective at preventing malaria when taken correctly, so the choice between them usually comes down to logistics rather than which one "works better." Malarone is a daily pill with a short 7-day tail after your trip and no special lab work required. Tafenoquine is a once-weekly pill that is easier to remember on a long trip, but it requires a blood test to confirm you are not G6PD deficient before you can take it, and that test needs to happen with enough lead time to get results back. Below is a real decision framework, not just a features table, to help you and your clinician land on the right one for your specific trip.

The Core Tradeoff in One Paragraph

Malarone asks for more frequent action (a pill every single day) but fewer prerequisites (no special testing, short post-trip course, fast start). Tafenoquine asks for less frequent action (one pill a week) but more upfront setup (a mandatory G6PD test, a 3-day loading dose before you leave, and a dose in the week after you return). If you are the kind of traveler who reliably takes a daily vitamin without thinking about it, Malarone's simplicity wins. If you know daily pills are the thing that derails you on trips, or you are heading out for many weeks and dread the idea of a daily habit for that long, tafenoquine's weekly schedule may be worth the extra setup step.

Dosing Side by Side

Malarone's 7-day post-trip tail is the shortest of any first-line antimalarial; doxycycline and mefloquine both require a full 4 weeks after you leave. Tafenoquine's back end is also short (one dose the week after return) but its front end has more moving parts because of the loading dose and the mandatory testing.

The G6PD Test: The Deciding Factor for Many Travelers

This is the detail that changes the calculation for a lot of people. G6PD deficiency is a genetic condition that makes red blood cells vulnerable to breaking down when exposed to certain medications, including tafenoquine, and the reaction can be dangerous. Before anyone can be prescribed tafenoquine, a quantitative G6PD blood test has to confirm normal enzyme activity. That test itself is simple, but it takes time: you need to get the blood drawn, wait for lab results, and only then can a prescription be written. If you are booking a trip with only a few days' notice, this timeline can rule tafenoquine out even if it would otherwise be a good fit, since Malarone needs only 1 to 2 days of lead time with no lab work at all. If you travel malaria-risk regions repeatedly, getting a G6PD test done once, well before you need it, removes this obstacle for every future trip.

Cost Comparison

Generic atovaquone-proguanil (Malarone) typically runs $43 to $245 for a 30-tablet adult supply, and our full Malarone cost breakdown covers what drives that range and how to pay less. Tafenoquine does not yet have a widely available generic in the same way, and the G6PD test itself is an additional cost most travelers do not factor in upfront, whether billed through insurance or paid out of pocket. If cost is the deciding factor, Malarone (especially the generic) is usually the more predictable and often lower-cost option once you account for the testing tafenoquine requires.

Side Effects: What's Different

Malarone's most common side effects are abdominal pain (13-17%), nausea (up to 12%), and headache (10-13%), and serious reactions are rare. Vivid dreams occur in roughly 2-7% of Malarone users. Tafenoquine carries the same general antimalarial side effect profile (headache, nausea, dizziness) plus the G6PD-related red blood cell risk that makes the pre-screening test mandatory, and it is not recommended for anyone with a history of psychotic illness. Neither drug carries the neuropsychiatric risk profile associated with mefloquine (Lariam), which is a separate, less-favored option for travelers with any history of anxiety, depression, or seizure disorders.

Who Tends to Prefer Each One

Malarone tends to fit better if: your trip was booked with short notice, you are traveling with children (Malarone has established weight-based pediatric dosing; tafenoquine is adults-only), you would rather avoid an extra blood draw, or your trip is short enough that a 7-day post-trip tail barely matters either way.

Tafenoquine tends to fit better if: you are on a long trip (weeks to months) and the idea of remembering a pill every single day for that entire stretch feels genuinely harder than a weekly one, you already know your G6PD status from a prior test, or you are a frequent malaria-zone traveler who wants to get the G6PD test done once and have the weekly option available for every future trip.

Neither is "the better drug" in a vacuum. The CDC treats atovaquone-proguanil, doxycycline, and tafenoquine as comparably effective when taken as directed, so this is genuinely a fit-to-your-trip decision rather than a chase for the most potent option. For the full dosing detail on tafenoquine, see Arakoda (Tafenoquine) for Malaria Prevention, and for Malarone's complete dosing picture, see Malarone Dosage, Side Effects & When to Start.

Start your free pre-trip health check and a Wandr clinician can help you decide between Malarone and tafenoquine based on your actual itinerary, timeline, and health history.

Frequently Asked Questions

Is tafenoquine more effective than Malarone? No. The CDC considers atovaquone-proguanil (Malarone), doxycycline, and tafenoquine equally effective at preventing malaria when taken correctly. The difference between them is dosing schedule, testing requirements, side effects, and cost, not raw effectiveness.

Do I have to get a G6PD test to take Malarone? No. G6PD testing is only required for tafenoquine (and primaquine), not for Malarone. This is one of the biggest practical differences between the two options.

Can children take tafenoquine instead of Malarone? No. Tafenoquine (Arakoda) is only approved for adults 18 and older. Malarone has established weight-based pediatric dosing and is generally the antimalarial of choice for traveling families.

Which is cheaper, Malarone or tafenoquine? Generic atovaquone-proguanil is usually the more predictable and often lower-cost choice, especially once you factor in the added cost and logistics of the mandatory G6PD test required for tafenoquine.

How far in advance do I need to plan for tafenoquine versus Malarone? Malarone needs just 1 to 2 days of lead time. Tafenoquine needs more: time to get a G6PD test and results back, plus a 3-day loading dose before you travel. If your trip is coming up fast, Malarone is the more realistic option.

Can I switch from Malarone to tafenoquine (or vice versa) for a future trip? Yes, as long as you meet the requirements for the one you are switching to, including a G6PD test if you are switching to tafenoquine for the first time. Tell your clinician which antimalarials you have used before and how you tolerated them.

Sources

• Centers for Disease Control and Prevention (CDC). Malaria: Choosing a Drug to Prevent Malaria. https://www.cdc.gov/malaria/php/public-health-strategy/choosing-a-drug-to-prevent-malaria.html
• CDC Yellow Book. Malaria. https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/malaria.html
• FDA. Arakoda (tafenoquine) Prescribing Information. https://www.accessdata.fda.gov
• FDA. Malarone (atovaquone and proguanil hydrochloride) Prescribing Information. https://www.accessdata.fda.gov

Medical disclaimer: This article is for general educational purposes and is not a substitute for personalized medical advice. The right antimalarial for you depends on your trip length, timeline, health history, and G6PD status. Always consult a licensed clinician before starting any antimalarial medication.